CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Search

We found 7252 result(s)

amifampridine (Ruzurgi)

Last Updated: April 23, 2021
Result type: Reports
Product Line: Reimbursement Review
Generic Name: amifampridine
Indications: Indicated for the symptomatic treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 years of age and older.

  • Brand Name: Ruzurgi
  • Manufacturer: Médunik Canada Inc.
  • Project Number: SR0660-000
  • Project Status: Active
  • Submission Type: Initial

encorafenib (Braftovi)

Last Updated: December 22, 2020
Result type: Reports
Product Line: Reimbursement Review
Generic Name: encorafenib
Indications: In combination with cetuximab, for the treatment of patients with metastatic colorectal cancer (mCRC) with a BRAF V600E mutation, as detected by a validated test, after prior therapy.

  • Brand Name: Braftovi
  • Manufacturer: Pfizer Canada ULC
  • Project Number: PC0233-000
  • Project Status: Active
  • Submission Type: Initial

Prevention of Tuberculosis Reactivation

Last Updated: May 4, 2021
Result type: Projects in Progress
Report Type: Summary with Critical Appraisal

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Bupropion for Major Depressive Disorder, Persistent Depressive Disorder (Dysthymia), or Treatment Resistant Depression

Last Updated: May 4, 2021
Result type: Projects in Progress
Report Type: Summary of Abstracts

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Phosphodiesterase-5 inhibitors for the Treatment of Secondary Raynaud's Phenomenon and Digital Ulcers

Last Updated: May 4, 2021
Result type: Projects in Progress
Report Type: Peer-reviewed summary with critical appraisal

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Conventional Disease-Modifying Anti-Rheumatic Drugs for the Treatment of Rheumatoid Arthritis

Last Updated: May 4, 2021
Result type: Projects in Progress
Report Type: Summary with Critical Appraisal

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Nasal Cannula Combined with Non-Rebreather Masks for Delivery of Oxygen

Last Updated: May 4, 2021
Result type: Projects in Progress
Report Type: Summary of Abstracts

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Evidence Related to Oncology

Last Updated: July 17, 2019
Result type: Resources

Here you'll find an up-to-date collection of CADTH’s oncology-related products. The bundle includes reports and other resources on a variety of topics related to the diagnosis and treatment of cancer. CADTH has reviewed the evidence on various cancer treatments, screening and diagnostic technologies, and ways to manage symptoms associated with c...